Conversely, lower anti-A60 IgA observed in patients with expectoration appears to contradict a recent report of increased anti-tuberculous glycolipid IgA in patients with cavitary TB and bronchoiectasis [41]—but this may reflect the difference in antigens evaluated. This evidence concerns the gene CD79A and tuberculosis.